- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
No Role for Ursodiol in Asymptomatic Cholelithiasis
Ursodiol has not been demonstrated to be very effective in stone dissolution.
In patients in whom cholelithiasis with numerous stones is incidentally noted on imaging, ursodeoxycholic acid should be considered to help dissolve the stones and reduce the risk of biliary disease.
a. True
b. False
ANSWER: FALSE
Ursodeoxycholic acid (ursodiol) has not been demonstrated to be very effective in stone dissolution. The prevalence of cholelithiasis is up to 20% in Western countries; the majority of patients will remain symptom-free over their life-time. There is currently no role for the use of ursodiol in these patients.
Clinical Tips for Using Antibiotics and Corticosteroids in IBD
January 5th 2013The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.
